Order Article Reprints

Menegatti J, Nakel J, Stepanov YK, Caban KM, Ludwig N, Nord R, Pfitzner T, Yazdani M, Vilimova M, Kehl T, et al. Changes of Protein Expression after CRISPR/Cas9 Knockout of miRNA-142 in Cell Lines Derived from Diffuse Large B-Cell Lymphoma. Cancers. 2022; 14(20):5031. https://doi.org/10.3390/cancers14205031

Menegatti, Jennifer, Jacqueline Nakel, Youli K. Stepanov, Karolina M. Caban, Nicole Ludwig, Ruth Nord, Thomas Pfitzner, Maryam Yazdani, Monika Vilimova, Tim Kehl, and et al. 2022. "Changes of Protein Expression after CRISPR/Cas9 Knockout of miRNA-142 in Cell Lines Derived from Diffuse Large B-Cell Lymphoma" Cancers 14, no. 20: 5031. https://doi.org/10.3390/cancers14205031

Menegatti, J., Nakel, J., Stepanov, Y. K., Caban, K. M., Ludwig, N., Nord, R., Pfitzner, T., Yazdani, M., Vilimova, M., Kehl, T., Lenhof, H.-P., Philipp, S. E., Meese, E., Fröhlich, T., Grässer, F. A., & Hart, M. (2022). Changes of Protein Expression after CRISPR/Cas9 Knockout of miRNA-142 in Cell Lines Derived from Diffuse Large B-Cell Lymphoma. Cancers, 14(20), 5031. https://doi.org/10.3390/cancers14205031